Courtney McKnight
Courtney McKnight, DrPH
NYU School of Global Public Health - Clinical Assistant Professor
DrPH, Public Health, CUNY Graduate Center
MPH, Public Health, Hunter College
BA, Sociology, Rutgers University
Research Interests
Substance use policy, Health care access for people who use drugs
Courtney McKnight has over 20 years of public health experience, with a significant background in socio-behavioral research related to substance use, as well as field experience as a harm reduction service provider. Dr. McKnight served as the Assistant Director of Research at the Chemical Dependency Institute (CDI) at the Icahn School of Medicine at Mount Sinai. During her tenure at CDI, Dr. McKnight served as co-investigator and project director on numerous federally funded research studies, including evaluations of health promotion programs, interventions to increase access to medical care, and investigations of the drivers that contribute to disparate rates of disease. In addition to her professional experience, Dr. McKnight completed her doctoral degree in Public Health at the CUNY Graduate Center. Her dissertation was focused on investigating the impact of Medicaid coverage of methadone and buprenorphine on treatment access for opioid dependent Medicaid beneficiaries. Dr. McKnight’s current research interests include substance use policy and health care accessibility for people who use drugs.
Principal Investigator, Comparison of Stigmatization of Monkeypox, Injecting Drug Use, HIV/AIDS, and COVID-19. Active
Principal Investigator, Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19. Active
Principal Investigator, Examination of Opioid Overdose Prevention Behaviors Among People Who Use Drugs. Completed
Principal Investigator, Knowledge and Perceptions of Fentanyl Among Opioid Users and Service Providers. Completed
Principal Investigator, Poly Drug Use and Overdose Risk Among Individuals Using Methamphetamine and Opioids. Completed


Des Jarlais DC, Weng CA, Feelemyer J, McKnight C (2023).
COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
Harm Reduction Journal, 20 (1), 63. doi: 10.1186/s12954-023-00791-0. PMCID: PMC10156073.

Des Jarlais D, Bobashev G, Feelemyer J, McKnight C (2022).
Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
Drug and Alcohol Dependence, 238, 109573. doi: 10.1016/j.drugalcdep.2022.109573. PMCID: PMC9278993.

Barnes DM, Xu S, Cleland CM, McKnight C, Des Jarlais D (2022).
Recurrent injecting drug use as a mediator between psychiatric disorder and non-fatal overdose
Substance Use and Misuse, 57 (8), 1248-1256. doi: 10.1080/10826084.2022.2076877.

Hwahng SJ, Allen B, Zadoretzky C, Doucet HB, McKnight C, Des Jarlais D (2022).
Thick trust, thin trust, social capital, and health outcomes among trans women of color in New York City
International Journal of Transgender Health, 23 (1-2), 214-231. doi: 10.1080/26895269.2021.1889427. PMCID: PMC8986172.

Des Jarlais DC, Feelemyer J, McKnight C, Knudtson K, Glick SN (2021).
Is your syringe services program cost-saving to society? A methodological case study
Harm Reduction Journal, 18 (1), 126. doi: 10.1186/s12954-021-00575-4. PMCID: PMC8650283.

Dr. McKnight's MyBibliography Profile
Selected Press